Stroe-Kunold Esther, Buckert Magdalena, Friederich Hans-Christoph, Wesche Daniela, Kopf Stefan, Herzog Wolfgang, Wild Beate
Department of General Internal Medicine and Psychosomatics, Medical University Hospital, Heidelberg, Germany.
Department of Psychosomatic Medicine and Psychotherapy, LVR-Clinics, University Düsseldorf, Düsseldorf, Germany.
PLoS One. 2016 Dec 28;11(12):e0166843. doi: 10.1371/journal.pone.0166843. eCollection 2016.
Leptin, a hormone secreted by adipose tissue, appears to play a major role in the homeostasis of body weight and psychobiological processes associated with anorexia nervosa (AN). However, there is scarce data on its exact influence on this disorder, in particular data over time.
The present study addresses whether leptin changes during inpatient treatment play a role for treatment outcome and psychological factors in underweight AN patients.
In order to understand whether leptin's role differs in relation to AN severity, data were assessed from 11 patients with a very low BMI and a higher chronicity (high severity group; HSS; mean BMI at the beginning of the study = 13.6; mean duration of illness = 5.1 years) vs. nine with less severe symptoms (LSS; mean BMI = 16.2; mean duration of illness = 3.7 years). During the course of treatment, serum leptin concentrations were assessed weekly while weight (BMI) was assessed twice per week. Concomitantly, psychological variables were obtained by means of electronic diaries. Unconditional linear growth models were calculated to evaluate the temporal course of leptin in relation to BMI. For HSS patients, two phases of treatment (BMI < 16 and BMI ≥ 16 kg/m2) were investigated.
Leptin increased significantly with BMI in both groups of patients. For HSS patients, the increase of leptin in the first treatment phase did not predict later increases in BMI. Furthermore, the relationship of leptin and psychological factors was modulated by symptom severity. In HSS patients, higher leptin levels were associated with greater feelings of depression, anxiety, and stress whereas in LSS patients a higher leptin level showed the trend to be associated with lower psychological symptom burden.
Our results suggest that leptin changes are differently associated with weight gain and psychological symptoms depending on the severity of starvation.
瘦素是一种由脂肪组织分泌的激素,似乎在体重稳态以及与神经性厌食症(AN)相关的心理生物学过程中发挥着重要作用。然而,关于其对这种疾病的确切影响,尤其是长期数据却很匮乏。
本研究探讨住院治疗期间瘦素的变化是否对体重过轻的AN患者的治疗结果和心理因素产生影响。
为了解瘦素的作用是否因AN严重程度而异,对11名BMI极低且病程较长(高严重程度组;HSS;研究开始时平均BMI = 13.6;平均病程 = 5.1年)的患者与9名症状较轻(低严重程度组;LSS;平均BMI = 16.2;平均病程 = 3.7年)的患者的数据进行了评估。在治疗过程中,每周评估血清瘦素浓度,同时每周评估两次体重(BMI)。此外,通过电子日记获取心理变量。计算无条件线性增长模型以评估瘦素相对于BMI的时间进程。对于HSS患者,研究了两个治疗阶段(BMI < 16和BMI≥16 kg/m²)。
两组患者的瘦素水平均随BMI显著升高。对于HSS患者,第一治疗阶段瘦素的升高并未预测后期BMI的增加。此外,瘦素与心理因素的关系受症状严重程度的调节。在HSS患者中,较高的瘦素水平与更强烈的抑郁、焦虑和压力感相关,而在LSS患者中,较高的瘦素水平显示出与较低心理症状负担相关的趋势。
我们的结果表明,根据饥饿的严重程度,瘦素变化与体重增加和心理症状的关联有所不同。